{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:42:44Z","timestamp":1791106964297,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.neulet.2008.12.003","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T05:30:31Z","timestamp":1228627831000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Neuroprotective effects of (\u00b1)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice"],"prefix":"10.1016","volume":"450","author":[{"given":"Haolan","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2008.12.003_bib1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0891-5849(02)01137-1","article-title":"Uptake and metabolism of epicatechin and its access to the brain after oral ingestion","volume":"33","author":"Abd El Mohsen","year":"2002","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.neulet.2008.12.003_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0024-3205(90)90018-M","article-title":"Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP","volume":"46","author":"Arora","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2008.12.003_bib3","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1021\/jf000026+","article-title":"Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk","volume":"48","author":"Arts","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neulet.2008.12.003_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-510X(90)90225-C","article-title":"The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease","volume":"97","author":"Bloem","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2008.12.003_bib5","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2008.12.003_bib6","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1096\/fj.04-1551fje","article-title":"Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death","volume":"18","author":"Chen","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2008.12.003_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neulet.2008.12.003_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1254\/jphs.FPJ04053X","article-title":"(+)-Catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest","volume":"98","author":"Huang","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2008.12.003_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10715769800300401","article-title":"Oral administration of (\u2212)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil","volume":"29","author":"Inanami","year":"1998","journal-title":"Free Radical Res."},{"key":"10.1016\/j.neulet.2008.12.003_bib10","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1021\/jf010903r","article-title":"Different effects of five catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells","volume":"49","author":"Jin","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neulet.2008.12.003_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00001756-200504250-00016","article-title":"Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress","volume":"16","author":"King","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2008.12.003_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molbrainres.2003.07.003","article-title":"Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase\/Akt and glycogen synthase kinase-3","volume":"118","author":"Koh","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neulet.2008.12.003_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.brainres.2006.10.055","article-title":"Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells","volume":"1129","author":"Lee","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2008.12.003_bib14","doi-asserted-by":"crossref","first-page":"30574","DOI":"10.1074\/jbc.M202832200","article-title":"Involvement of protein kinase C activation and cell survival\/cell cycle genes in green tea polyphenol (\u2212)-epigallocatechin 3-gallate neuroprotective action","volume":"277","author":"Levites","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2008.12.003_bib15","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2008.12.003_bib16","first-page":"376","article-title":"Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation","volume":"26","author":"Li","year":"2006","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.neulet.2008.12.003_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1046\/j.1471-4159.1999.01901.x","article-title":"CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults","volume":"73","author":"Maroney","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2008.12.003_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neulet.2008.12.003_bib19","first-page":"175","article-title":"Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephalic cells","volume":"136","author":"Nobre Junior","year":"2003","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"key":"10.1016\/j.neulet.2008.12.003_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0738-3991(95)00757-Q","article-title":"Parkinson's disease\u2014medical education and psychosocial aspects","volume":"26","author":"Oertel","year":"1995","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.neulet.2008.12.003_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neulet.2008.12.003_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/bj3580547","article-title":"Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3","volume":"358","author":"Schroeter","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.neulet.2008.12.003_bib23","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/carcin\/19.10.1771","article-title":"Wide distribution of [3H](\u2212)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue","volume":"19","author":"Suganuma","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neulet.2008.12.003_bib24","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2008.12.003_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2003.10.012","article-title":"SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Wang","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2008.12.003_bib26","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","article-title":"Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity","volume":"52","author":"Wang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2008.12.003_bib27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jnutbio.2004.05.002","article-title":"Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases","volume":"15","author":"Weinreb","year":"2004","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neulet.2008.12.003_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2008.12.003_bib29","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394008016844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394008016844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:09:16Z","timestamp":1759608556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394008016844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0304394008016844"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2008.12.003","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of (\u00b1)-catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2008.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}